Novo Nordisk's Wegovy receives FDA approval to treat serious liver disease

Welcome back. Shares of Nova Nordis jumping this morning. You can see up almost 5% on a number of headlines that surround its weight loss and diabetes drugs.They're often the same drug. Angelica Peoples uh just got off the phone with uh Nova Nordisk executives and has some more details for us. Angelica, hey David.Well, yeah, that's a busy morning for Novo. Let's start with the first. The FDA is approving Novo's weight loss drug for a liver condition and this is the latest condition that the GLP-1 is approve ...